Latest Industry Insights

David Curtin discusses how the integration of MALS detectors with Empower software enhances biopharmaceutical QC, aligns with evolving regulatory demands and supports the future of complex biologic product analysis.

Learn more about how AI is advancing the mRNA drug discovery pipeline and what we can expect to see in the future in this interview with Dr. Davide De Lucrezia.

As the global population ages, the need for innovative solutions to extend health span and combat age-related diseases has never been more urgent. LinkGevity, a pioneering AI-enabled drug discovery company, is at the forefront of this challenge.

James Connelly discusses the importance of third-party verification and how recent funding will help accelerate the development of Impact Laboratories' digital sustainability tools.

Technology Networks spoke with Dr. Irina Babina, chief executive officer of Concr, to explore the origins of the company, the science behind its platform and the tangible impact it hopes to deliver for patients and healthcare systems alike.

In this interview, Sebastiaan J. Trietsch, Chief Technology Officer at MIMETAS, discusses how microphysiological systems are advancing drug discovery through scalable human-relevant models and AI integration.

The integration of AI and automation is transforming laboratory research, improving overall efficiency and scalability. However, scientists must be cautious as over-reliance on AI may weaken critical thinking and troubleshooting skills.

Dalip Sethi provides valuable insights on how AI is currently being carefully and critically considered within the cell and gene therapy industry, with regard to data and technological preparedness.

A specialist in flow cytometry, cell sorting and cellular biology, Dr. Richard Cuthbert shared his perspectives on the current and future applications of flow cytometry – and automated flow cytometry systems – in modern drug discovery.

Technology Networks spoke with Dr. Richard Cuthbert, cell biology product manager at Bio-Rad, to learn more about Bio-Rad's new ZE5 Cell Analyzer, the challenges within the field and recent technological advancements in flow cytometry.